Send me a link:

*Text messaging rates may apply.

 Dow Up 0.04% Nasdaq Up 0.21%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
6.58 Up 0.19(2.97%) 11:16AM EDT - Nasdaq Real Time Price
Prev Close:6.39
Open:6.24
Bid:6.63 x 1700
Ask:6.65 x 300
1y Target Est:12.75
Beta:1.85
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:6.16 - 6.76
52wk Range:6.04 - 13.64
Volume:1,503,343
Avg Vol (3m):987,943
Market Cap:285.02M
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACRXUp 2.97%285.02M
BAXUp 0.24%41.59B
CFNDown 0.33%9.30B
HSPDown 0.66%8.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Jun-14) :-0.26
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback